Alleghany Corporation’s Novartis NVS Stock Holding History

Alleghany Corporation’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-27,900	Closed	-$2.46M	–	52
2015 Q1	$2.46M	Hold	27,900	–	–	0.09%	47
2014 Q4	$2.32M	Hold	27,900	–	–	0.09%	51
2014 Q3	$2.35M	Hold	27,900	–	–	0.09%	47
2014 Q2	$2.26M	Hold	27,900	–	–	0.08%	48
2014 Q1	$2.13M	Hold	27,900	–	–	0.09%	48
2013 Q4	$2.01M	Hold	27,900	–	–	0.1%	50
2013 Q3	$1.92M	Hold	27,900	–	–	0.1%	50
2013 Q2	$1.77M	Buy	+27,900	New	+$1.82M	0.1%	49

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Alleghany Corporation's NVS Position: Q2 2015 in Review

Alleghany Corporation sold out of Novartis (NVS) in Q2 2015, closing a stake of 27,900 shares — an estimated $2.46M sold.

Alleghany Corporation first reported a position in NVS in Q2 2013 and held it in 8 quarters. The position peaked at $2.46M in Q1 2015. 943 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

Alleghany Corporation reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
Alleghany Corporation sold 27,900 Novartis shares in Q2 2015, an estimated $2.46M.
Alleghany Corporation first reported a position in Novartis in Q2 2013 and held it in 8 quarters.
Alleghany Corporation's Novartis position peaked at $2.46M in Q1 2015.
943 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Alleghany Corporation's 13F filing for Q2 2015, filed 5 Aug 2015.